Heart rate dynamics during a treadmill cardiopulmonary exercise test in optimized beta-blocked heart failure patients

Heart rate dynamics during a treadmill cardiopulmonary exercise test in optimized beta-blocked heart failure patients

BACKGROUND: Calculating the maximum heart rate for age is one method to characterize the maximum effort of an individual. Although this method is commonly used, little is known about heart rate dynamics in optimized beta-blocked heart failure patients. AIM: The aim of this study was to evaluate hear...

Full description

Bibliographic Details
Main Authors:	Vitor Oliveira Carvalho, Guilherme Veiga Guimarães, Emmanuel Gomes Ciolac, Edimar Alcides Bocchi
Format:	Article
Language:	English
Published:	Faculdade de Medicina / USP 2008-01-01
Series:	Clinics
Subjects:	Heart failure Heart rate Carvedilol Exercise Optimization
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322008000400011

Similar Items

HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA
by: A. A. Aleksandrov, et al.
Published: (2016-01-01)

The relationship between heart rate reserve and oxygen uptake reserve in heart failure patients on optimized and non-optimized beta-blocker therapy
by: Vitor Oliveira Carvalho, et al.
Published: (2008-01-01)

Can the Cardiopulmonary 6-Minute Walk Test Reproduce the Usual Activities of Patients with Heart Failure?
by: Guilherme Veiga Guimarães, et al.
Published: (2002-06-01)

Effect of carvedilol versus nebivolol on insulin resistance among non-diabetic, non-ischemic cardiomyopathy with heart failure
by: Yasser Gaber Metwally, et al.
Published: (2020-09-01)

Impact of Gly389Arg 1-adrenoceptor polymorphism on the risk of chronic heart failure, the nature of its course, and on the efficiency of its treatment with carvedilol
by: Aleksandr Trofimovich Teplyakov, et al.
Published: (2010-12-01)

Thrombotic event prevention in patients with post-infarction chronic heart failure, as а part of complex therapy including various classes of beta -adrenoblockers
by: Yu. V. Larina, et al.
Published: (2008-12-01)

Carvedilol therapy effects on structural and electric remodeling in chronic heart failure
by: E. V. Minakov, et al.
Published: (2008-02-01)

Reproducibility of the self-controlled six-minute walking test in heart failure patients
by: Guilherme Veiga Guimarães, et al.
Published: (2008-01-01)

Carvedilol and its combination with digoxin for heart rate control in patients with persistent atrial fibrillation and chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Exercise and heart failure. Relation of the severity of the disease to the anaerobic threshold and the respiratory compensation point
by: Guilherme Veiga Guimarães, et al.
Published: (1999-10-01)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
by: A. N. Zakirova, et al.
Published: (2015-12-01)

Hemodynamic and endotheliym-protective effects of beta-blockers in patients with chronic heart failure and atrial fibrillation ischemic origin
by: Aliara N. Zakirova, et al.
Published: (2020-09-01)

The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
by: Ki Hong Choi, et al.
Published: (2019-09-01)

Carvedilol Alters Circulating MiR-1 and MiR-214 in Heart Failure
by: Shirazi-Tehrani E, et al.
Published: (2020-09-01)

COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION
by: M. E. Statsenko, et al.
Published: (2016-01-01)

Hemodynamic and endothelium-protective effects of β-adrenoblockers in patients with coronary heart disease complicated by chronic heart failure and atrial fibrillation
by: A. N Zakirova, et al.
Published: (2010-03-01)

Effects of Exercise, Clenbuterol, Carvedilol, Dobutamine, and Sedentary Existence in Acute Imipramine-Induced Heart Failure in Rat
by: Sutayatram, Saikaew, DVM
Published: (2014)

Biomarkers of IL-33 and sST2 and Lack of Association with Carvedilol Therapy in Heart Failure
by: Firouzabadi N, et al.
Published: (2020-06-01)

Current strategies for preventing renal dysfunction in patients with heart failure: a heart failure stage approach
by: Victor Sarli Issa, et al.
Published: (2013-01-01)

Norepinephrine remains increased in the six-minute walking test after heart transplantation
by: Guilherme Veiga Guimarães, et al.
Published: (2010-01-01)

Inverse correlation between testosterone and ventricle ejection fraction, hemodynamics and exercise capacity in heart failure patients with erectile dysfunction
by: Edimar A. Bocchi, et al.
Published: (2008-06-01)

Benefits of exercise training in the treatment of heart failure: study with a control group
by: Mário Sérgio Vaz da Silva, et al.
Published: (2002-10-01)

Carvedilol effectiveness in complex treatment of patients with arterial hypertension, coronary heart disease, and Type 2 diabetes mellitus
by: R. M. Shakirova, et al.
Published: (2007-10-01)

Long-term carvedilol therapy effects on left ventricular remodeling and glycemia in patients with chronic heart failure and Type 2 diabetes mellitus
by: R. R. Samedov, et al.
Published: (2008-02-01)

HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD
by: A. A. Abdullaev, et al.
Published: (2016-01-01)

Heart Rate Response During Treadmill Exercise Test in Children and Adolescents With Congenital Heart Disease
by: Fabian von Scheidt, et al.
Published: (2019-03-01)

Validação da versão em português do Minnesota Living with Heart Failure Questionnaire Validación de la versión en portugués del Minnesota Living with Heart Failure Questionnaire Validation of the Portuguese version of the Minnesota Living with Heart Failure Questionnaire
by: Vitor Oliveira Carvalho, et al.
Published: (2009-07-01)

How should the cardiopulmonary exercise test be interpreted in heart failure?
by: Yalçın Velibey
Published: (2019-09-01)

The course of patients with Chagas heart disease during episodes of decompensated heart failure
by: Victor Sarli Issa, et al.
Published: (2021-04-01)

Cardiopulmonary Interactions with Consecutive Pulmonary Abnormalities in Patients with Chronic Heart Failure
by: Ivan Alerić, et al.
Published: (2017-01-01)

Effect of exercise training and carvedilol treatment on cardiac function and structure in mice with sympathetic hyperactivity-induced heart failure
by: A. Medeiro, et al.
Published: (2008-09-01)

THE EFFECTIVENESS OF CARVEDILOL AND EPROSARTAN IN PATIENTS WITH METABOLIC SYNDROME AND CHRONIC HEART FAILURE
by: R. L. Dashnamirov
Published: (2014-04-01)

Heart rate kinetics during standard cardiopulmonary exercise testing in heart transplant recipients: a longitudinal study
by: Oliver Schumacher, et al.
Published: (2021-04-01)

LEFT VENTRICLE DIASTOLIC DYSFUNCTION IN PATIENTS WITH ANTERIOR WALL MYOCARDIAL INFARCTION AND DRUG PREVENTION OF CONGESTIVE HEART FAILURE (A LONG-TERM OBSERVATION)
by: M. T. Beyshenkulov, et al.
Published: (2003-08-01)

HEART FAILURE, DEPRESSION AND EXERCISE
by: Areti Tsaloglidou, Dr., et al.
Published: (2019-11-01)

Changes in heart rate variability with respect to exercise intensity and time during treadmill running
by: Kenneth J. Hunt, et al.
Published: (2018-09-01)

The β-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi
by: Aline Luciano Horta, et al.
Published: (2018-10-01)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
by: Kenneth D. Varian, et al.
Published: (2020-10-01)

COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY
by: I. V. Zhirov, et al.
Published: (2015-09-01)

Cardiopulmonary Exercise Test in Advanced Heart Failure Among Heart Transplantation Candidates
by: Alireza Eslaminejad, et al.
Published: (2018-11-01)